Literature DB >> 15343109

[Therapeutic education of patients receiving anticoagulants for thromboembolic venous disease: description of the Educ'AVK program].

S Léger1, B Allenet, J Calop, J L Bosson.   

Abstract

Educ'AVK is an education program designed for patients starting an oral anticoagulant treatment following a thromboembolic event (deep venous thrombosis or pulmonary embolism). Patients enrolled are judged capable of self-management of their drug treatment. The intervention, adapted to a short-term treatment, consists in an 3-step one-on-one teaching session conducted by a trained pharmacist. 1) Identification of the patient's needs--or educational diagnosis. 2) Definition of educational objectives adapted, first, to the patient's cognition: to be able to describe indications for therapy and potential risks factors for anticoagulant bleeding, to interpret INR lab tests and to solve a problematic treatment situation related second, to the patient's behaviour: to be able to anticipate the risk (how to enhance compliance, how to deal with a missed dose.), to take relevant decisions when dealing a therapeutic incident (bleeding, INR outside of the targeted range). 3) Choice of appropriate teaching contents and methods to reach the objectives. We used the "individual guidance" technique associated with original tools: a picture book to describe the pathology and the treatment; a booklet synthesizing all the information given by the educator during the consultation. This booklet presents 3 key-points: the information is specifically targeted to thromboembolic venous disease; the information integrates the risk-level of the patient (3 different booklets according to the patient's level of risk, of bleeding, of thromboemboly, no specific risk); there is a section where the patient writes down his/her INR results in a table specifically adapted to his/her risk level--bleeding, thromboemboly, no specific risk--and giving recommendations for the management of INR out of the targeted range.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15343109     DOI: 10.1016/s0398-0499(04)96736-4

Source DB:  PubMed          Journal:  J Mal Vasc        ISSN: 0398-0499


  4 in total

1.  EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study.

Authors:  Gilles Pernod; José Labarère; Jacqueline Yver; Bernadette Satger; Benoit Allenet; Touffek Berremili; Michèle Fontaine; Guy Franco; Jean Luc Bosson
Journal:  J Gen Intern Med       Date:  2008-06-20       Impact factor: 5.128

Review 2.  Self-monitoring and self-management of oral anticoagulation.

Authors:  Carl J Heneghan; Josep M Garcia-Alamino; Elizabeth A Spencer; Alison M Ward; Rafael Perera; Clare Bankhead; Pablo Alonso-Coello; David Fitzmaurice; Kamal R Mahtani; Igho J Onakpoya
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05

3.  [Evaluation of the level of knowledge of patients on treatment with vitamin K antagonists in Ouagadougou cardiology department].

Authors:  André Samadoulougou; Dangwé Temoua Naibe; Germain Mandi; Relwendé Aristide Yameogo; Elisé Kabore; Georges Millogo; Nobila Valentin Yameogo; Jonas Koudougou Kologo; Anna Thiam Tall; Boubacar Jean Yves Toguyeni; Patrice Zabsonre
Journal:  Pan Afr Med J       Date:  2014-11-15

4.  A multicenter, prospective study evaluating the impact of the clinical pharmacist-physician counselling on warfarin therapy management in Lebanon.

Authors:  Nermine S Choumane; Diana N Malaeb; Bassem Malaeb; Souheil Hallit
Journal:  BMC Health Serv Res       Date:  2018-02-01       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.